Using fractional exhaled nitric oxide to guide step down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis
<p><strong>Background</strong> High fractional exhaled nitric oxide (FeNO) levels are associated with greater risk of asthma exacerbations. However, it is not clear how FeNO can be used to guide safe reductions in inhaled corticosteroid (ICS) doses in asthma patients. This study as...
| Principais autores: | , , , , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
European Respiratory Society
2020
|